{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,7]],"date-time":"2026-02-07T15:43:39Z","timestamp":1770479019993,"version":"3.49.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2005,12,1]],"date-time":"2005-12-01T00:00:00Z","timestamp":1133395200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Urology"],"published-print":{"date-parts":[[2005,12]]},"DOI":"10.1016\/j.urology.2005.06.117","type":"journal-article","created":{"date-parts":[[2005,12,22]],"date-time":"2005-12-22T18:48:05Z","timestamp":1135277285000},"page":"1197-1202","source":"Crossref","is-referenced-by-count":26,"title":["Frequency and clinicopathologic correlates of ErbB1, ErbB2, and ErbB3 immunoreactivity in urothelial tumors of upper urinary tract"],"prefix":"10.1016","volume":"66","author":[{"given":"Yuh-Shyan","family":"Tsai","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tzong-Shin","family":"Tzai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan-Haw","family":"Chow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chao-Liang","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.urology.2005.06.117_bib1","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1002\/(SICI)1097-0142(19990315)85:6<1342::AID-CNCR17>3.0.CO;2-B","article-title":"Unusual clinical presentation of upper urothelial carcinoma in Taiwan","volume":"85","author":"Chou","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib2","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S0090-4295(02)01529-7","article-title":"Unusually high incidence of upper urinary tract urothelial carcinoma in Taiwan","volume":"59","author":"Yang","year":"2002","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.06.117_bib3","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1046\/j.1464-410x.2000.00344.x","article-title":"A clinicopathologic study of bladder cancer associated with upper urinary tract cancer","volume":"85","author":"Miyake","year":"2000","journal-title":"BJU Int"},{"key":"10.1016\/j.urology.2005.06.117_bib4","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S0022-5347(17)54881-8","article-title":"Management of high-grade transitional cell cancer of the upper urinary tract","volume":"135","author":"Murphy","year":"1981","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.06.117_bib5","first-page":"1957","article-title":"Expression profiles of ErbB family receptors and prognosis in primary transitional cell carcinoma of the urinary bladder","volume":"7","author":"Chow","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib6","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1200\/JCO.2004.03.118","article-title":"p53, p21, pRB, and p16 expression predict clinical outcome in cystectomy with bladder cancer","volume":"22","author":"Shariat","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2005.06.117_bib7","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1200\/JCO.2004.05.174","article-title":"Combined effects of p53, p21, and pRb expression in the progression of bladder transitional cell carcinoma","volume":"22","author":"Chatterjee","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.urology.2005.06.117_bib8","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1016\/S0022-5347(01)66855-1","article-title":"Histopathologic features and p53 nuclear protein staining as predictors of survival and tumor recurrence in patients with transitional cell carcinoma of renal pelvis","volume":"54","author":"Terrell","year":"1995","journal-title":"J Urol"},{"key":"10.1016\/j.urology.2005.06.117_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1038\/bjc.1995.14","article-title":"Significance of epidermal growth factor receptor and c-ErbB-2 protein expression in transitional cell cancer of the upper urinary tract for tumor recurrence at the urinary bladder","volume":"71","author":"Imai","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib10","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.urology.2004.08.025","article-title":"HER2 protein overexpression and gene amplification in upper urinary tract transitional cell carcinoma","volume":"65","author":"Langner","year":"2005","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.06.117_bib11","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/(SICI)1097-0142(19960815)78:4<827::AID-CNCR20>3.0.CO;2-W","article-title":"The proliferation index of MIB-1 as a prognostic factor for patients with transitional cell carcinoma of the upper urinary tract","volume":"78","author":"Chowdhury","year":"1996","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib12","first-page":"1863","article-title":"The prognostic value of angiogenesis and metastasis-related genes for progression of transitional cell carcinoma of the renal pelvis and ureter","volume":"8","author":"Inoue","year":"2002","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib13","doi-asserted-by":"crossref","first-page":"6115","DOI":"10.1038\/sj.onc.1203972","article-title":"Overexpression of ErbB2 in cancer and ErbB2-targeting strategies","volume":"19","author":"Yu","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2005.06.117_bib14","first-page":"2422","article-title":"c-ErbB-2 gene amplification","volume":"55","author":"Underwood","year":"1995","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib15","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1038\/sj.onc.1203272","article-title":"Signal transduction in mammary tumorigenesis","volume":"19","author":"Dankort","year":"2000","journal-title":"Oncogene"},{"key":"10.1016\/j.urology.2005.06.117_bib16","first-page":"4157","article-title":"Overexpression of epidermal growth factor receptor in urothelium elicits urothelial hyperplasia and promotes bladder tumor growth","volume":"62","author":"Cheng","year":"2002","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib17","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1159\/000072676","article-title":"Prognostic values of p53 and HER-2\/neu coexpression in invasive bladder cancer in Taiwan","volume":"71","author":"Tsai","year":"2003","journal-title":"Urol Int"},{"key":"10.1016\/j.urology.2005.06.117_bib18","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S1078-1439(03)00176-5","article-title":"The prevalence and clinicopathologic correlate of p16INK4a, retinoblastoma and p53 immunoreactivity in locally advanced urinary bladder cancer","volume":"22","author":"Tzai","year":"2004","journal-title":"Urol Oncol"},{"key":"10.1016\/j.urology.2005.06.117_bib19","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1093\/jnci\/90.18.1346","article-title":"erbB-2, p53, and efficacy of adjuvant therapy in lymph node-positive breast cancer","volume":"90","author":"Thor","year":"1998","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/j.urology.2005.06.117_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s004280050056","article-title":"Expression patterns of ErbB receptor family in normal urothelium and transitional cell carcinoma","volume":"430","author":"Chow","year":"1997","journal-title":"Virchows Arch"},{"key":"10.1016\/j.urology.2005.06.117_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1002\/ijc.10731","article-title":"HER2 overexpression in muscle-invasive urothelial carcinoma of the bladder","volume":"102","author":"Kruger","year":"2002","journal-title":"Int J Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib22","first-page":"2440","article-title":"HER-2\/neu overexpression in muscle-invasive urothelial carcinoma of the bladder","volume":"7","author":"Jimenez","year":"2001","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib23","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1038\/sj.bjc.6601245","article-title":"HER2\/neu overexpression in the development of muscle-invasive transitional cell carcinoma of the bladder","volume":"89","author":"Latif","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib24","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1042\/0264-6021:3560087","article-title":"Heterodimerization of the epidermal-growth-factor (EGF) receptor and ErbB2 and the affinity of EGF binding are regulated by different mechanisms","volume":"356","author":"Johannessen","year":"2001","journal-title":"Biochem J"},{"key":"10.1016\/j.urology.2005.06.117_bib25","first-page":"6227","article-title":"A subclass of HER1 ligands is prognostic marker for survival in bladder cancer patients","volume":"61","author":"Thogersen","year":"2001","journal-title":"Cancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib26","first-page":"1293","article-title":"Significance of urinary epidermal growth factor and its receptor expression in human bladder cancer","volume":"17","author":"Chow","year":"1997","journal-title":"Anticancer Res"},{"key":"10.1016\/j.urology.2005.06.117_bib27","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/cncr.11691","article-title":"The development of bladder tumors and contralateral upper urinary tract tumors after primary transitional cell carcinoma of the upper urinary tract","volume":"98","author":"Kang","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/j.urology.2005.06.117_bib28","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/S0090-4295(99)00563-4","article-title":"Risk factors for the development of bladder cancer after upper tract urothelial cancer","volume":"55","author":"Hisataki","year":"2000","journal-title":"Urology"},{"key":"10.1016\/j.urology.2005.06.117_bib29","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1097\/01.ju.0000107767.56680.f7","article-title":"The impact of tumor location on the prognosis of transitional cell carcinoma of the upper urinary tract","volume":"171","author":"Park","year":"2004","journal-title":"J Urol"}],"container-title":["Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950500926X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S009042950500926X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,12]],"date-time":"2019-04-12T02:45:20Z","timestamp":1555037120000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S009042950500926X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,12]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2005,12]]}},"alternative-id":["S009042950500926X"],"URL":"https:\/\/doi.org\/10.1016\/j.urology.2005.06.117","relation":{},"ISSN":["0090-4295"],"issn-type":[{"value":"0090-4295","type":"print"}],"subject":[],"published":{"date-parts":[[2005,12]]}}}